Roche has received positive news from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), which has recommended the approval of PiaSky (crovalimab) for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). This recommendation marks a significant step forward in offering a new treatment option for adults and adolescents (12 years and older, … Read more
The European Medicines Agency’s committee for human medicines (CHMP) has made a critical decision regarding the medicine Ocaliva (obeticholic acid), recommending that its marketing authorization be revoked across the European Union. This decision comes after a thorough review concluded that the benefits of Ocaliva no longer outweigh its risks for the treatment of primary biliary … Read more
Merck, known as MSD outside of the United States and Canada, has received a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for its new drug Winrevair (sotatercept). This recommendation is for the treatment of pulmonary arterial hypertension (PAH) in adult patients with World Health … Read more
Venus Concept Inc, a global leader in medical aesthetic technology, has successfully concluded its series of NEXThetics events across major cities in North America. These gatherings have grown significantly in popularity and attendance, with thousands of registrants participating, including a record-setting event in Houston, Texas on June 22, 2024. Dr. Cheryl Haseeb from Pura Medical … Read more
Antengene Corporation Limited (Antengene), a prominent global biopharmaceutical company, has announced a significant milestone: South Korea’s National Health Insurance Service (NHIS) has approved reimbursement for Xpovio (selinexor) starting July 1, 2024. This approval marks Xpovio’s inclusion in South Korea’s national reimbursed drugs list for treating adult patients with relapsed or refractory multiple myeloma (R/R MM). … Read more
Stalicla SA, a Swiss neuro precision biotech company specializing in precision medicine for neuropsychiatric and neurodevelopmental disorders, has announced the publication of a significant phase 1b study on STP1. This novel combination therapy is tailored for treating a specific subgroup of patients with autism spectrum disorder (ASD) known as ASD Phenotype 1 (ASD-Phen1). Published in … Read more
Pharmexcil, the Pharmaceuticals Export Promotion Council of India, is set to resume discussions with Russia’s SBER Bank in New Delhi by the end of June 2024. This meeting aims to tackle challenges faced by exporters and address issues related to the Rupee-Rouble trade arrangement, crucial for trade between India and Russia. Pharmexcil is urging its … Read more
Diabetes specialists in India are increasingly concerned about foot infections among diabetic patients, as these often lead to serious complications like lower limb amputations. Currently, about 15% of diabetics in India suffer from diabetic foot infections (DFI), which are commonly caused by bacteria like Pseudomonas, E. coli, and S. aureus. The recent guidelines from the … Read more
The All Kerala Chemists and Druggists Association (AKCDA) plans to approach District Magistrates and District Child Protection Units (DCPUs) to request an extension of the deadline for installing CCTV surveillance cameras in their shops. They also seek exemptions for small-scale traders with a daily turnover below Rs. 1,500, as well as shops located away from … Read more
In May 2024, the Production Linked Incentive (PLI) scheme for pharmaceuticals saw a notable investment of Rs. 940 crore, marking a 3.32% increase from April’s Rs. 28,328 crore to Rs. 29,268 crore. According to the Department of Pharmaceuticals (DoP), actual production surged by 12.3% in May to Rs. 1,61,209 crore, compared to Rs. 1,43,553 crore … Read more
